226 related articles for article (PubMed ID: 2723427)
1. Platelet deactivation by 5HT2-receptor blockade parallels the antihypertensive response to ketanserin.
Amstein R; Fetkovska N; Pletscher A; Bühler FR
J Hypertens; 1989 Apr; 7(4):255-60. PubMed ID: 2723427
[TBL] [Abstract][Full Text] [Related]
2. Age, platelet serotonin kinetics and 5HT2-receptor blockade in essential hypertension.
Amstein R; Fetkovska N; Bühler FR
J Hum Hypertens; 1990 Aug; 4(4):441-4. PubMed ID: 2258891
[TBL] [Abstract][Full Text] [Related]
3. Age and 5HT 2-receptor blockade with ketanserin in essential hypertension.
Bühler FR; Amstein R
Rev Port Cardiol; 1989 Sep; 8(9):621-4. PubMed ID: 2698721
[TBL] [Abstract][Full Text] [Related]
4. Platelet serotonin-LDL interaction in essential hypertension.
Amstein R; Fetkovska N; Bühler FR
J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S35-40. PubMed ID: 1717771
[TBL] [Abstract][Full Text] [Related]
5. Effects of ketanserin administration on lipid metabolism and platelet aggregation in hypertensive patients.
Loschiavo C; Valvo E; Bedogna V; Casagrande P; Graziani MS; Nicoli M; Maschio G
Int J Clin Pharmacol Ther Toxicol; 1990 Nov; 28(11):455-7. PubMed ID: 2272704
[TBL] [Abstract][Full Text] [Related]
6. Double-blind comparison of ketanserin with atenolol: antihypertensive activity and effect on platelet function.
Kirch W; Ohnhaus EE
J Hypertens Suppl; 1986 Apr; 4(1):S67-71. PubMed ID: 2939216
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
Amery A; Fagard R; Fiocchi R; Lijnen P; Staessen J; Vermylen J
J Cardiovasc Pharmacol; 1984; 6(1):182-5. PubMed ID: 6199602
[TBL] [Abstract][Full Text] [Related]
8. Acute effect of urapidil on peripheral serotonin metabolism.
Sebeková K; Fedelesová V; Blazícek P; Dzúrik R
Cor Vasa; 1990; 32(4):274-81. PubMed ID: 2225876
[TBL] [Abstract][Full Text] [Related]
9. The effect of ketanserin on blood pressure and platelets during cardiopulmonary bypass.
Lichtenthal PR; Wade LD; Rossi EC
Anesth Analg; 1987 Nov; 66(11):1151-4. PubMed ID: 3662060
[TBL] [Abstract][Full Text] [Related]
10. Serotonin metabolism and age-related effects of antihypertensive therapy with ketanserin.
Amstein R; Fetkovska N; Ferracin F; Pletscher A; Bühler FR
Drugs; 1988; 36 Suppl 1():61-6. PubMed ID: 2467792
[TBL] [Abstract][Full Text] [Related]
11. Effects of ketanserin and mepyramine on platelet aggregation and on the uptake of 5-hydroxytryptamine into platelets.
Bevan J; Heptinstall S
Thromb Res; 1983 Jun; 30(5):415-23. PubMed ID: 6612677
[TBL] [Abstract][Full Text] [Related]
12. Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double-blind, placebo-controlled cross-over study.
Arneklo-Nobin B; Elmér O; Akesson A
Int Angiol; 1988; 7(1):19-25. PubMed ID: 3290356
[TBL] [Abstract][Full Text] [Related]
13. Serotonin and platelet activation during treatment with isradipine.
Fetkovska N; Sebekova K; Fedelesova V; Dzurik R
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S31-3. PubMed ID: 1720482
[TBL] [Abstract][Full Text] [Related]
14. Age and the platelet serotonin vasoconstrictor axis in essential hypertension.
Amstein R; Fetkovska N; Lüscher TF; Kiowski W; Bühler FR
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S35-40. PubMed ID: 2459512
[TBL] [Abstract][Full Text] [Related]
15. Effects of urapidil on 5-hydroxytryptamine induced platelet aggregation and on 14C-5-hydroxytryptamine uptake in platelets.
Storck J; Ochs JG; Kirsten R
Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):303-8. PubMed ID: 2387654
[TBL] [Abstract][Full Text] [Related]
16. Serotonin metabolism and platelet aggregation under antihypertensive treatment with nitrendipine.
Sebeková K; Raucinová M; Sedláková K; Dzúrik R
J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S161-3. PubMed ID: 2468865
[TBL] [Abstract][Full Text] [Related]
17. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP
Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
[TBL] [Abstract][Full Text] [Related]
18. 5HT-kinetics and sensitivity of human blood platelets: variations with age, gender and platelet number.
Fetkovska N; Amstein R; Ferracin F; Regenass M; Bühler FR; Pletscher A
Thromb Haemost; 1988 Dec; 60(3):486-90. PubMed ID: 2467403
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive mechanism of ketanserin in postoperative hypertension after cardiopulmonary bypass.
Anger C; Carter JA; Prys-Roberts C
Anesth Analg; 1988 Feb; 67(2):99-106. PubMed ID: 3277483
[TBL] [Abstract][Full Text] [Related]
20. Effects of ketanserin on blood pressure and platelet aggregation in elderly men with mild hypertension.
Egan B; Conlon ME; Campbell R; Schork N; Zwiefler A; Julius S
Am J Hypertens; 1988 Jul; 1(3 Pt 3):324S-330S. PubMed ID: 3415805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
